Hims & Hers Health Inc (NYSE:HIMS) shares are soaring Wednesday after the company announced plans to introduce at-home lab ...
Hims & Hers Health shares reached another all-time high after the company said it plans to introduce at-home lab testing through its platform after buying an at-home testing facility, Sigmund NJ.
By acquiring Sigmund NJ LLC, known as Trybe Labs, Hims & Hers will be able "to support at-home blood draws and more ...
Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are calling out advertisement of prescription of injectable weight-loss drugs without ...
Hims & Hers is introducing at-home laboratory testing, expanding its platform to offer deeper health insights and more ...
Hims & Hers is introducing at-home laboratory testing, expanding its platform to offer deeper health insights and more ...
Hims & Hers is expanding its offerings through the Trybe Labs deal after it added compounded weight loss drugs.
Hims & Hers announced its plans to introduce at-home lab testing through its platform. The company has acquired an at-home lab testing ...
Hims & Hers Health Inc. is expanding beyond its successful foray into providing copycat weight-loss drugs with the ...
Hims & Hers Health, Inc., the leading health and wellness platform, today announced its plans to introduce at-home lab ...
The acquisition of Trybe Labs, marketed as Sigmund NJ LLC, will enable Hims & Hers to offer comprehensive whole body testing, including at-home blood draws. This addition to the company’s services is ...
The Super Bowl aired a Hims & Hers commercial that is receiving backlash for its non-FDA approved weight loss drug. This drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results